Navigation Links
Hanger Appoints Melissa Debes as Chief Accounting Officer
Date:9/3/2014

AUSTIN, Texas, Sept. 3, 2014 /PRNewswire/ -- Hanger, Inc. (NYSE: HGR) today announced it has appointed Melissa Debes as Vice President and Chief Accounting Officer, effective September 8, 2014.  Ms. Debes has served as Corporate Controller at Hanger since March 11, 2014.  

"In the few months Melissa has been with us, she has strengthened our accounting processes while fostering increased collaboration between our staff, our auditors, and our external financial consultants," Hanger President and CEO Vinit Asar said.  "As a Six Sigma accounting executive with tremendous leadership experience at large public companies, Melissa has already cultivated a good momentum here at Hanger and is well-poised to drive significant improvements in our financial systems and processes." 

With more than 30 years' experience in financial management, driving profitability, cost reduction, and improving financial performance, Ms. Debes's extensive background includes GAAP technical roles with public companies as well as finance positions that involved forecasting, analysis, and strategic planning.  Prior to joining Hanger, Ms. Debes served most recently as Interim Chief Accounting Officer at Valerus Oil & Gas Services and as Chief Accounting Officer at ENER1.  From 2001 to 2010, she served as Vice President of Finance in Corporate Planning & Analysis, Product Group and Technology Finance and in various other financial roles of increasing responsibility at Advanced Micro Devices (AMD), a global technology company dedicated to computing and graphic products.  Prior to her time at AMD, Ms. Debes spent 15 years leading finance in various positions at Motorola.

Ms. Debes holds a Bachelor of Science degree in Finance from Arizona State University and a Master of Business Administration from the Thunderbird School of Global Management.

About Hanger, Inc. – Built on the legacy of James Edward Hanger, the first amputee of the American Civil War, Hanger, Inc. (NYSE: HGR) delivers orthotic and prosthetic (O&P) patient care, and distributes O&P products and rehabilitative solutions to the broader market.  Hanger's Patient Care segment is the largest owner and operator of O&P patient care clinics with in excess of 770 locations nationwide. Through its Products & Services segment, Hanger distributes branded and private label O&P devices, products and components, and provides rehabilitative solutions.  Steeped in over 150 years of clinical excellence and innovation, Hanger's vision is to be the partner of choice for products and services that enhance human physical capability.  For more information on Hanger, visit www.hanger.com and follow us at www.Facebook.com/HangerNews, www.Twitter.com/HangerNews, and www.YouTube.com/HangerNews.


'/>"/>
SOURCE Hanger, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Truveris Launches RxDash, a Game-Changer that Allows Instant Price and Plan Design Modeling for Pharmacy Benefits Changes
2. Hanger Announces Appointment of Asif Ahmad to Board of Directors
3. Hanger Reschedules Second Quarter 2014 Earnings Release and Conference Call
4. Hanger to Release Second Quarter 2014 Results on Tuesday, August 5 After Market Close and Host Conference Call at 9:00 am Eastern on Wednesday, August 6
5. Hanger Announces Appointment of Christopher B. Begley to Board of Directors
6. The Airway Company Launches Revolutionary New Speaking Valve And Heat Moisture Exchanger
7. Hanger Reports Third Quarter 2013 Results
8. Hanger Announces 2013 Year-To-Date Acquisitions Totaling $10 Million Of Annualized Net Revenue
9. Hanger Reports Second Quarter 2013 Results
10. Hanger Enters New 5-Year Credit Agreement to Refinance Senior Secured Credit Facilities
11. Hanger elects Thomas P. Cooper, M.D. Chairman of the Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... , March 28, 2017  Medeon Biodesign, Inc., ... company, is pleased to announce that the Company ... of Panther Orthopedics, Inc., a San ... fixation solutions for orthopedic extremity applications.  ... expand rapidly, primarily due to procedure volume growth, ...
(Date:3/28/2017)... LONDON , March 28, 2017  "US ... insight on the various indicators and trend analysis ... generics drugs in mainstream pharmaceutical market in US. ... responsible for the growth on cancer generics drugs ... resulted in saving of billions of dollars for ...
(Date:3/28/2017)... 28, 2017  Orexigen Therapeutics, Inc. (Nasdaq: ... the fourth quarter and year ended December 31, 2016. ... transformational progress for Orexigen, beginning with the re-acquisition of ... early March, the team at Orexigen demonstrated remarkable focus, ... reshaped and strengthened our Company while rewarding us full ...
Breaking Medicine Technology:
(Date:3/28/2017)... NEW YORK (PRWEB) , ... March 28, 2017 ... ... development, NTX Technology™, is the first technology to directly address the resolution to ... Organization. NTX Technology™ is a patented compound of FDA and TTB approved ingredients ...
(Date:3/28/2017)... ... ... Dr. Isabella Wentz, PharmD, FASCP, one of the leading thyroid experts of ... Dr. Wentz talked about journey and research recently on a blog and discussed some ... only solution to deal with thyroid disease. , Dr. Wentz completed her graduation ...
(Date:3/28/2017)... ... March 28, 2017 , ... Alert Sentry Group LLC., a ... Personal Emergency Response Systems), the iSAFE and the iSAFE Plus. These iSAFE products are ... of their kind, the iSAFE and iSAFE Plus offer direct GPS Location and two-way ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... instruments are critical to ensuring high-quality results and maintaining GMP and USP compliance. ... Laboratory Instruments in accordance with GMP requirements " these requirements are explained. ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... corrosive ions found in power plant water and steam. , Chlorides and sulfates ... and boilers, leading to extensive maintenance and unplanned shutdowns. Monitoring these ions at ...
Breaking Medicine News(10 mins):